Why the study?
Does percutaneous repair improve outcomes in patients with left ventricular dysfunction and secondary mitral regurgitation?
Does percutaneous repair improve outcomes in patients with left ventricular dysfunction and secondary mitral regurgitation?
Answers are grounded in this paper and cite their sources.
This editorial discusses the role of percutaneous repair for secondary mitral regurgitation in patients with left ventricular dysfunction.
The mitral valve is a complex structure encompassing the valve leaflets, annulus, chordae tendineae, and papillary muscles.1 Primary mitral regurgitation is caused by a primary leaflet abnormality, whereas secondary mitral regurgitation occurs when structurally normal valve leaflets are unable to coapt completely owing to distortion of the supporting apparatus resulting from an ischemic or dilated cardiomyopathy. Current guidelines recommend early surgery for severe primary mitral regurgitation,2,3 but the management of secondary mitral regurgitation, which is essentially a disease of the left ventricle, is more controversial. Patients who have left ventricular dysfunction and secondary mitral regurgitation of any severity have a . . .
No takes yet. Share an insight, caveat, or question.
Nishimura et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: